S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Adar1 Capital Management/Q2 2024

Adar1 Capital Management

Periodo: Q2 2024 · Depositato: 2024-08-13
Vedi su SEC EDGAR
AUM
$530M
Valore totale del portafoglio
Posizioni
266
Titoli dichiarati
Prima Posizione
PTGX
10.5% $55.6M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2024-08-13) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
PTGXPROTAGONIST THERAPEUTICS INC$55.6M10.49%$35.20$131.62+273.9%
10.5%
CYTKCYTOKINETICS INC$46.3M8.73%$54.70$86.49+58.1%
8.7%
ROIVROIVANT SCIENCES LTD$43.9M8.28%$10.83$35.13+224.4%
8.3%
BOXXEA SERIES TRUST$37.9M7.15%$107.54$117.22+9.0%
7.2%
BBIOBRIDGEBIO PHARMA INC$32.0M6.05%$25.20$77.19+206.3%
6.0%
RPRXROYALTY PHARMA PLC$31.1M5.88%$24.90$57.77+132.0%
5.9%
KROSKEROS THERAPEUTICS INC$25.1M4.74%$43.77$11.26-74.3%
4.7%
INSMPUTINSMED INC$13.4M2.54%$66.34$111.60+68.2%
2.5%
IMVTIMMUNOVANT INC$12.6M2.38%$27.51$38.79+41.0%
2.4%
ABUSARBUTUS BIOPHARMA CORP$10.2M1.92%$3.12$4.87+56.1%
1.9%
INSMCALLINSMED INC$10.1M1.90%$66.34$111.60+68.2%
1.9%
MRKMERCK & CO INC$9.4M1.77%$119.72$129.56+8.2%
1.8%
RZLTREZOLUTE INC$8.9M1.68%$4.31$4.91+13.9%
1.7%
SLDBSOLID BIOSCIENCES INC$8.1M1.52%$6.27$10.84+72.9%
1.5%
EWTXEDGEWISE THERAPEUTICS INC$7.9M1.48%$19.38$39.56+104.1%
1.5%
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.5M1.42%$10.08$11.00+9.1%
1.4%
ASNDASCENDIS PHARMA A/S$7.0M1.32%$133.98$274.50+104.9%
1.3%
TECXTECTONIC THERAPEUTIC INC$5.9M1.11%$15.90$37.93+138.6%
1.1%
QUREUNIQURE NV$5.5M1.03%$4.45$41.81+839.5%
1.0%
ABSIABSCI CORPORATION$5.2M0.99%$3.01$11.62+286.1%
1.0%
VKTXVIKING THERAPEUTICS INC$4.8M0.91%$55.32$37.44-32.3%
0.9%
ALKSALKERMES PLC$4.7M0.89%$24.39$54.58+123.8%
0.9%
SPYPUTSPDR S&P 500 ETF TR$4.3M0.82%$532.73$744.78+39.8%
0.8%
HLXBHELIX ACQUISITION CORP II$4.1M0.78%
0.8%
ANABANAPTYSBIO INC$3.9M0.74%$16.41$63.42+286.5%
0.7%
CERECEREVEL THERAPEUTICS HLDNG I$3.8M0.72%
0.7%
CRNXCRINETICS PHARMACEUTICALS IN$3.4M0.63%$46.07$42.23-8.3%
0.6%
BILSPDR SER TR$3.0M0.56%$84.38$91.44+8.4%
0.6%
INSMINSMED INC$2.8M0.53%$66.34$111.60+68.2%
0.5%
QTTBQ32 BIO INC$2.8M0.53%$18.98$13.09-31.0%
0.5%

Attività Trimestre su Trimestre

Q2 2024 vs. Q1 2024

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
RZLTREZOLUTE INC$8.9M+13.9%
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.5M+9.1%
TECXTECTONIC THERAPEUTIC INC$5.9M+138.6%
CRNXCRINETICS PHARMACEUTICALS IN$3.4M-8.3%
KALAKALA BIO INC$2.2M
KNSAKINIKSA PHARMACEUTICALS INTL$2.1M
BEAMBEAM THERAPEUTICS INC$1.7M
SLNOSOLENO THERAPEUTICS INC$1.6M

Posizioni Chiuse (8)

TickerEmittenteNozionale
MACKMERRIMACK PHARMACEUTICALS IN$13.3M
AVROAVROBIO INC$5.1M
FUSNFUSION PHARMACEUTICALS INC$3.8M
REGNREGENERON PHARMACEUTICALS$2.2M
SDGRSCHRODINGER INC$1.7M
LLYELI LILLY & CO$1.4M
NGMNGM BIOPHARMACEUTICALS INC$1.3M
KNSAKINIKSA PHARMACEUTICALS LTD$1.2M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
BBIOPUTBRIDGEBIO PHARMA INC$32.0M+105280.8%+206.3%
CYTKCALLCYTOKINETICS INC$46.1M+34054.5%+58.1%
MRKMERCK & CO INC$9.3M+25150.0%+8.2%
ANABCALLANAPTYSBIO INC$3.9M+15479.9%+286.5%
SVRACALLSAVARA INC$2.6M+11750.0%
INSMINSMED INC$13.4M+11711.8%+68.2%
INSMINSMED INC$10.0M+8723.5%+68.2%
RLMDRELMADA THERAPEUTICS INC$0.1M+8319.5%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CYTKCALLCYTOKINETICS INC$-22.4M-100.0%+58.1%
BBIOPUTBRIDGEBIO PHARMA INC$-17.0M-99.8%+206.3%
APLSCALLAPELLIS PHARMACEUTICALS INC$-1.5M-99.6%
BBIOPUTBRIDGEBIO PHARMA INC$-16.9M-99.3%+206.3%
ALNYALNYLAM PHARMACEUTICALS INC$-34.6M-99.2%
ALNYALNYLAM PHARMACEUTICALS INC$-26.5M-99.0%
TYRATYRA BIOSCIENCES INC$-0.5M-98.9%
GOSSCALLGOSSAMER BIO INC$-0.8M-97.3%
Torna agli Hedge Fund